Uninsured Infertility Patients in the NY Tri-State Area Get Access to Affordable IVF Care Through WINFertility® - Program Expands with 4 Prestigious Fertility Practices

New York Tri-State residents can access unique program that bundles IVF treatment AND medications, with below-market rates for each IVF treatment cycle. The program is now available in 8 locations in New York, New Jersey and Connecticut.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fertility Starts Here.
The practices also serve as the Division of Reproductive Endocrinology at leading Tri-State Hospital Medical Centers, collectively helping thousands of patients on their path to parenthood each year.

White Plains, NY (PRWEB) January 31, 2013

WINFertility, Inc., the leader in Infertility Management Programs for insurers and employers, today announced the extension of its consumer offering throughout the metropolitan New York area, including Central New Jersey and Southern Connecticut. This marks its 22nd state and 27th location where consumers can access the unique WINFertility Program. The current expansion is designed to increase the availability of high quality, affordable ivf treatment that remains financially out of reach for many of the over five million NY Tri-State residents facing infertility today who are without advanced infertility insurance coverage. Additional access is planned in the near future.

Unlike any other solution in the market today WINFertility simplifies, streamlines and discounts fertility treatments for uninsured patients seeking to have a baby. State-of-the-art, evidence-based treatment programs for IUI, IVF and Third Party Reproduction are delivered by WINFertility’s contracted, credentialed network of fertility specialists. Infertility medications are included in the single, discounted, bundled price. There is no age or medical criteria required to enroll in the Program. If treatment is indicated by a participating provider and the patient has no infertility insurance coverage, or has exhausted their benefit, she can enroll in the WINFertility Program. Typical patient savings per IVF treatment cycle in the Greater New York area range from 10% to 40% or more, depending on specific treatments and medication doses required.

Incorporated in the unique Consumer Program is access to WINFertility’s FertilityCoach Nurses(SM) on a 24/7 basis for education and care coordination, a Medical Advisory Board comprised of industry-leading Reproductive Endocrinologists and financing programs at preferred rates.

WINFertility’s Network Programs Deliver High-Quality Care to Patients in Brooklyn, Staten Island, Long Island and Westchester County, NY, Middlesex County, NJ and Fairfield County, CT.

Effective today, the WINFertility Treatment Program is available in 8 convenient locations throughout metro NY through four leading fertility practices: Greenwich Fertility & IVF Center, P.C., Genesis Fertility & Reproductive Medicine, Island Reproductive Services and Reproductive Center of Central New Jersey.

Each of the four prominent practices is led by double board-certified Reproductive Endocrinologists and has achieved among the highest IVF success rates across all age groups in the Tri-State region. Additionally, the practices serve as the Division of Reproductive Endocrinology and Infertility at leading Hospital Medical Centers: Greenwich Hospital, Maimonides Medical Center and Staten Island University Hospital. Collectively, these successful fertility programs help thousands of patients on their path to parenthood each year.

Each of the WINFertility provider programs boast free-standing, fully accredited, state-of-the-art IVF facilities and laboratories, specifically developed to accommodate advanced fertility treatments and microsurgical procedures. The experienced teams of fellowship-trained specialists provide a full range of infertility services, from female and male testing and diagnosis, through IUI, IVF, Donor Programs and pre-implantation genetic diagnosis (PGD). Fertility Preservation, Recurrent Pregnancy Loss, Endometriosis and PCOS programs are also offered.

More Access for More Patients

“The Tri-State area has over 32 million people who call it home. We are excited to be able to offer our unique program across a wide expanse of one of the country’s largest and most dynamic marketplaces, where so many struggle with infertility and its associated expenses,” commented Tom Boyajy, COO of WINFertility. “The WINFertility approach is to promote high quality infertility care at the most competitive cost. By affiliating with four admired fertility programs in the region, we are confident that WINFertility patients will be the recipients of both compassionate, patient-centered care and excellent clinical results. Coupled with WINFertility’s proprietary, bundled packages, fertility management expertise, and considerable buying power, we are convinced that Tri-State residents in NY, NJ and CT can now receive the very best IVF treatment value possible.”

“The reception WINFertility has received about our Consumer Program continues to be extremely positive” said Boyajy. “This heartening response is due to the compelling financial and clinical benefits of WINFertility’s offering that are distinct from other programs in every marketplace we have entered. The NY metro area is a critically important market for us as it represents one of the largest and most densely populated regions in the US. We are very proud to now be able to help so many who suffer from infertility, particularly in our own home base of NY. We are confident our expansion in this region will continue as we grow to meet consumer demand.”

About WINFertility

Founded in 2000, WINFertility is the national leader in Infertility Management Programs, annually managing infertility treatment for many thousands of infertility patients for major insurers and employers. WINFertility is leveraging their decade-long experience and clinical results in the fertility field, direct contracts with fellowship-trained fertility specialists, pharmaceutical manufacturers and national specialty pharmacies, to offer this unique direct-to-consumer program. Now, patients without infertility insurance coverage in twenty-two states can take advantage of WINFertility’s integrated platform to access evidence-based protocols, high-quality providers and discounts enjoyed only by the largest healthcare purchasers. For more information, visit us at http://www.winfertility.com.


Contact